More about
Filamentous Keratitis
News
October 19, 2024
1 min read
Save
Patients on ovarian cancer drug require ophthalmology follow-up due to corneal toxicity
CHICAGO — Patients treated with mirvetuximab require close follow-up with an ophthalmologist due to the potential for corneal toxicity, according to a study.